Frontlight ResearchEarly access
Trial site
UOMI Cancer Center-Clinica Tres Torres
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Asthma1 trial
- Phase
- Phase 33 trials
- Phase 21 trial
- Status
- Recruiting2 trials
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Amgen1 trial
- Fondazione Ricerca Traslazionale1 trial
- GlaxoSmithKline1 trial
- Zai Lab (Shanghai) Co., Ltd.1 trial
Running trials
Recruiting
Active, not recruiting
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026